PROBLEMS WITH P53 IMMUNOHISTOCHEMICAL STAINING - THE EFFECT OF FIXATION AND VARIATION IN THE METHODS OF EVALUATION

被引:126
作者
FISHER, CJ
GILLETT, CE
VOJTESEK, B
BARNES, DM
MILLIS, RR
机构
[1] GUYS HOSP,ICRF,CLIN ONCOL UNIT,LONDON SE1 9RT,ENGLAND
[2] MASARYK INST ONCOL,CS-65653 BRNO,CZECH REPUBLIC
关键词
D O I
10.1038/bjc.1994.4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The availability of antibodies which recognise p53 protein in paraffin-embedded tissue has created the opportunity to use immunohistochemistry to study the expression of p53 in a wide variety of clinical material. In this paper we have investigated the relationship between the type of fixative and the pattern of p53 staining in mammary carcinoma. Optimal results were obtained from breast tissue fixed in phenol formol saline, methacarn or cold formol saline with positive staining for stabilised p53 protein occurring in 69/95 (73%) cases studied. Care must be taken in the interpretation of these results since positive staining for p53 protein is not always indicative of mutation of the p53 gene. Furthermore, a range of staining patterns is seen in mammary carcinomas, making interpretation difficult. Assessment of staining needs to be standardised in order that different studies can be compared. However, in breast carcinoma, p53 immunohistochemistry appears to give information relating to tumour grade and, independently, to prognosis.
引用
收藏
页码:26 / 31
页数:6
相关论文
共 28 条
[1]   ASSOCIATION OF P53 PROTEIN EXPRESSION WITH TUMOR-CELL PROLIFERATION RATE AND CLINICAL OUTCOME IN NODE-NEGATIVE BREAST-CANCER [J].
ALLRED, DC ;
CLARK, GM ;
ELLEDGE, R ;
FUQUA, SAW ;
BROWN, RW ;
CHAMNESS, GC ;
OSBORNE, CK ;
MCGUIRE, WL .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (03) :200-206
[2]   IMMUNOHISTOCHEMICAL DETECTION OF P53 PROTEIN IN MAMMARY-CARCINOMA - AN IMPORTANT NEW INDEPENDENT INDICATOR OF PROGNOSIS [J].
BARNES, DM ;
DUBLIN, EA ;
FISHER, CJ ;
LEVISON, DA ;
MILLIS, RR .
HUMAN PATHOLOGY, 1993, 24 (05) :469-476
[3]   IMMUNOHISTOCHEMICAL ANALYSIS OF THE P53 ONCOPROTEIN ON PARAFFIN SECTIONS USING A SERIES OF NOVEL MONOCLONAL-ANTIBODIES [J].
BARTEK, J ;
BARTKOVA, J ;
LUKAS, J ;
STASKOVA, Z ;
VOJTESEK, B ;
LANE, DP .
JOURNAL OF PATHOLOGY, 1993, 169 (01) :27-34
[4]   PATTERNS OF EXPRESSION OF THE P53 TUMOR SUPPRESSOR IN HUMAN BREAST TISSUES AND TUMORS INSITU AND INVITRO [J].
BARTEK, J ;
BARTKOVA, J ;
VOJTESEK, B ;
STASKOVA, Z ;
REJTHAR, A ;
KOVARIK, J ;
LANE, DP .
INTERNATIONAL JOURNAL OF CANCER, 1990, 46 (05) :839-844
[5]  
BOBROW LG, 1993, J PATHOL S, V169, P137
[6]  
BODNER SM, 1992, ONCOGENE, V7, P743
[7]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[8]   P53 EXPRESSION IN BREAST-CANCER [J].
CATTORETTI, G ;
RILKE, F ;
ANDREOLA, S ;
DAMATO, L ;
DELIA, D .
INTERNATIONAL JOURNAL OF CANCER, 1988, 41 (02) :178-183
[9]  
COOPER L S, 1992, Journal of Pathology, V167, p137A
[10]  
DAVIDOFF AM, 1991, SURGERY, V110, P259